By Professor Michael Proinsias Farrell

Books

Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London

Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health

Teesson M; Hall W; Proudfoot H; Degenhardt LJ, 2012, Addictions, Psychology Press Ltd, East Essex, UK, http://www.psypress.com/addictions-9780415583008

, 2007, Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Baker A; Velleman R, (ed.), Routledge, http://dx.doi.org/10.4324/9780203028513

Farrell MP, 2006, Sibling effects on divorce: common family background, common genetic heritage, or continuing interaction among adult siblings, http://dx.doi.org/10.1016/S1475-9144(06)05011-9

Teesson M; Degenhardt LJ; Hall WD, 2002, Addictions, Psychology Press, Sussex, UK

Book Chapters

Farrell M; Sevarino KA, 2024, 'Disorders due to Substance Use: Stimulants', in Tasman’s psychiatry, Fifth Edition, pp. 2843 - 2932, http://dx.doi.org/10.1007/978-3-030-51366-5_26

Farrell M; Larance B; Breen C, 2020, 'Opioids', in Geddes JR; Andreasen NC; Goodwin GM (ed.), New Oxford Textbook of Psychiatry, Oxford University Press, pp. 507 - 518, http://dx.doi.org/10.1093/med/9780198713005.003.0051

Wodak A, 2016, 'Aids and drug use: 'to shun the heaven that leads man to this Hell'', in International Handbook of Addiction Behaviour, pp. 126 - 133, http://dx.doi.org/10.4324/9781315542355

Farrell M, 2016, 'Physical complications of drug abuse', in International Handbook of Addiction Behaviour, pp. 120 - 125, http://dx.doi.org/10.4324/9781315542355

Glass IB; Farrell M; Hajek P, 2016, 'Tell me about the client: History-taking and formulating the case', in International Handbook of Addiction Behaviour, pp. 191 - 203, http://dx.doi.org/10.4324/9781315542355

Withall AL; Draper B; Johnco C, 2015, 'There's a tear in my beer: issues for the older patient with alcohol and substance abuse', in Haber P; Day C; Farrell M (ed.), Addiction Medicine: Principles and Practice, IP Communications, Melbourne, pp. 398 - 406

Berends L, 2014, 'Pathways of care', in Haber P; Day C; Farrell M (ed.), A short textbook of addiction medicine

Farrell M; Singleton N; Strang J, 2013, 'Drugs and prisons: A high risk and high burden environment', in Drug Use in Prisons, pp. 203 - 214, http://dx.doi.org/10.4324/9781315079998-17

Darker CD; Sweeney BP; Barry JM; Farrell MF, 2012, 'Psychosocial interventions for benzodiazepine harmful use, abuse or dependence', in Darker CD (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009652

Wodak AD; Ryan J; Griffiths P; van Beek I; Barratt M; Lenton S; Dolan K; Rodas AA; Noller G; Farrell M, 2012, 'Policy and practice in harm reduction in Australasia', in Pates R; Riley D (ed.), Harm Reduction in Substance Use and High-Risk Behaviour, Wiley-Blackwell, Chichester, UK, pp. 405 - 424, http://www.wiley.com/WileyCDA/WileyTitle/productCd-1118343352.html

Mayet S; Farrell M; Mani SG, 2010, 'Opioid agonist maintenance for opioid dependent patients in prison', in Mayet S (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008221

Hall W; Farrell M, 2008, 'Drug use and drug dependence', in Essential Psychiatry Fourth Edition, pp. 230 - 249, http://dx.doi.org/10.1017/CBO9780511544125.012

Knapp WP; Soares BGO; Farrel M; Lima MS, 2007, 'Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders', in , JOHN WILEY & SONS LTD, http://dx.doi.org/10.1002/14651858.CD003023.pub2

Flannery W; Farrell M, 2005, 'Forensic psychiatry and forensic psychology', in Encyclopedia of Forensic and Legal Medicine, pp. 405 - 416, http://dx.doi.org/10.1016/B0-12-369399-3/00167-1

Farrell M; Raistrick D, 2004, 'The coming of age of oral methadone maintenance treatment in the UK in the 1990s', in Heroin Addiction and the British System, pp. 104 - 118, http://dx.doi.org/10.4324/9780203643358

Strang J; Ruben S; Farrell M; Witton J; Keaney F; Gossop M, 2004, 'The history of prescribing heroin and other injectable drugs as addiction treatment in the UK', in Heroin Addiction and the British System, pp. 1 - 16, http://dx.doi.org/10.4324/9780203643358

Mayet S; Farrell M; Ferri M; Davoli M; Amato L, 2003, 'Psychosocial treatment for opiate abuse and dependence', in , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd004330

Gowing L; Farrell M; Bornemann R; Ali R, 2003, 'Substitution treatment of injecting opioid users for preventing transmission of HIV infection', in , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd004145

Farrell M; Hall W, 2003, 'Methadone and opioid-related deaths', in Methadone Matters, CRC Press, pp. 155 - 165, http://dx.doi.org/10.1201/b14312-19

Soares BGO; Lima MS; Farrell M, 2001, 'Psychosocial treatments for psychostimulants dependence', in Soares BGDO (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd003023

Silva de Lima M; Soares B; Farrell M, 2001, 'Psychosocial interventions for alcohol use disorders', in Silva de Lima M (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd003027

Strang J; Farrell M; Unnithan S, 1993, 'Treatment of Cocaine Abuse: Exploring the Condition and Selecting the Response', in Cocaine and Crack, Palgrave Macmillan UK, pp. 146 - 172, http://dx.doi.org/10.1007/978-1-349-22773-0_8

Journal articles

Darke S; Farrell M; Hall W; Lappin J, 2025, '‘Deaths of despair’: A term that needs to be retired', Addiction, 120, pp. 1072 - 1074, http://dx.doi.org/10.1111/add.70030

Woods A; Foley C; Conigrave KM; Asare-Doku W; Shakeshaft A; Settumba-Stolk S; Farrell M; Doyle M; Stolk SS, 2025, 'Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review', Addiction, 120, pp. 835 - 859, http://dx.doi.org/10.1111/add.16766

Jones N; Ghouse FN; Gibson A; Tran DT; Santo T; Bharat C; Farrell M; Degenhardt L, 2025, 'Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia', International Journal of Epidemiology, 54, http://dx.doi.org/10.1093/ije/dyaf037

Weatherburn D; Rahman S; Todd S; Poynton S; Black S; Merinda T; Farrell M, 2025, 'The impact of a voluntary alcohol and other drug diversion program on reoffending, imprisonment, and health', International Journal of Drug Policy, 138, pp. 104747, http://dx.doi.org/10.1016/j.drugpo.2025.104747

Darke S; Peacock A; Duflou JA; Farrell M; Lappin J, 2025, 'Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data', Medical Journal of Australia, 222, pp. 259 - 261, http://dx.doi.org/10.5694/mja2.52604

Pocuca N; Campbell G; Barnett A; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Stirling R; Hudson S; Hides L, 2025, 'A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment', Drug and Alcohol Review, 44, pp. 759 - 771, http://dx.doi.org/10.1111/dar.14007

Bharat C; Hopkins RE; Chambers M; Degenhardt L; Peacock A; Farrell M; Yuen WS; Man N; Gisev N, 2025, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019', Social Psychiatry and Psychiatric Epidemiology, 60, pp. 693 - 703, http://dx.doi.org/10.1007/s00127-024-02749-4

Darke S; Farrell M; Lappin J, 2025, 'Rare but relevant series', Addiction, 120, pp. 197, http://dx.doi.org/10.1111/add.16697

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2025, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, 44, pp. 366 - 375, http://dx.doi.org/10.1111/dar.13940

Darke S; Duflou J; Peacock A; Lim J; Havard A; Farrell M; Lappin J, 2025, 'Characteristics of deaths related to lithium toxicity in Australia, 2000–2024', Australian and New Zealand Journal of Psychiatry, http://dx.doi.org/10.1177/00048674251336037

Roberts E; Copeland C; Darke S; Farrell M, 2025, 'Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023', Drug and Alcohol Review, 44, pp. 347 - 354, http://dx.doi.org/10.1111/dar.13950

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Santo TJ; Chaillon A; Martin N; Hickman M; Jones N; Farrell M; Bharat C; Degenhardt L; Borquez A, 2025, 'Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study', Addiction, http://dx.doi.org/10.1111/add.70018

Pocuca N; Tisdale C; Campbell G; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Hides L, 2025, 'Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation', Drug and Alcohol Review, 44, pp. 226 - 238, http://dx.doi.org/10.1111/dar.13962

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730

Santo T; Chaillon A; Martin N; Bharat C; Jones N; Farrell M; Hickman M; Borquez A; Degenhardt L, 2025, 'Quantifying the Impact of Opioid Agonist Treatment on Suicide Mortality in New South Wales, Australia: A Population-Level Analysis from 2001 to 2020', Drug and Alcohol Dependence, 267, pp. 112133 - 112133, http://dx.doi.org/10.1016/j.drugalcdep.2024.112133

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Weatherburn D; Farrell M; Wan WY; Rahman S, 2024, 'The criminal careers of Australian drug traffickers', International Journal of Drug Policy, 134, pp. 104650, http://dx.doi.org/10.1016/j.drugpo.2024.104650

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Farnbach S; Foley C; Gates P; Seccull A; Henderson A; Zocco A; Farrell M; Shakeshaft A, 2024, 'Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1781 - 1786, http://dx.doi.org/10.1111/dar.13843

Heijstee N; Black E; Black E; Demirkol A; Mammen K; Mills L; Deacon R; Ezard N; Montebello M; Reid D; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Lintzeris N, 2024, 'Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia', Journal of Addiction Medicine, 18, pp. 619 - 627, http://dx.doi.org/10.1097/ADM.0000000000001311

Back to profile page